About Plexcera Therapeutics
Plexcera Therapeutics is a company based in Vero Beach (United States) founded in 2013 was acquired by Roivant Sciences in July 2016. Plexcera Therapeutics operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Vero Beach, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Roivant Sciences
(Jul 12, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Plexcera Therapeutics
Detailed funding history for Plexcera Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Plexcera Therapeutics
Plexcera Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Roivant Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Locked | Locked | Locked |
Investor details for Plexcera Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Plexcera Therapeutics
Investment portfolio details for Plexcera Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Plexcera Therapeutics
Detailed financials for Plexcera Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Plexcera Therapeutics Comparisons
Peer comparison for Plexcera Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Plexcera Therapeutics
Plexcera Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Plexcera Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Plexcera Therapeutics
Complete news archive for Plexcera Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Plexcera Therapeutics
Plexcera Therapeutics was founded in 2013.
Plexcera Therapeutics is headquartered in Vero Beach, United States. It is registered at Vero Beach, Florida, United States.
Plexcera Therapeutics was founded in 2013 and is based in Vero Beach, United States. Focus is placed on the biotechnology sector, where therapeutics for genetic diseases are developed. Recombinant human acid ceramidase (rhAC) is advanced as a key candidate, licensed from Mount Sinai Innovation Partners. This enzyme addresses deficiencies linked to cell growth and inflammation pathways. Pre-clinical trials are conducted for Farber disease and certain spinal muscular atrophy cases.
Plexcera Therapeutics's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Plexcera Therapeutics has 1 investor. Key investors include Roivant Sciences.